Trademark Overview
On Wednesday, July 30, 2025, a trademark application was filed for ONFARLA with the United States Patent and Trademark Office. The USPTO has given the ONFARLA trademark a serial number of 99310774. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 30, 2025. This trademark is owned by Corcept Therapeutics Incorporated. The ONFARLA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders.